UK markets close in 5 hours 46 minutes

Addex Therapeutics Ltd (0QNV.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
0.2355-0.0215 (-8.37%)
As of 03:43PM BST. Market open.
Currency in CHF

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.66
52-week change 3N/A
S&P500 52-week change 319.21%
52-week high 30.0000
52-week low 30.0000
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 526.37M
Implied shares outstanding 6N/A
Float 830.36M
% held by insiders 115.03%
% held by institutions 17.66%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-586.97%

Management effectiveness

Return on assets (ttm)-77.35%
Return on equity (ttm)-197.74%

Income statement

Revenue (ttm)2.15M
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)239.00%
Gross profit (ttm)1.44M
EBITDA -12.74M
Net income avi to common (ttm)-12.84M
Diluted EPS (ttm)-0.5260
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.17M
Total cash per share (mrq)0.1
Total debt (mrq)232.52k
Total debt/equity (mrq)3.80%
Current ratio (mrq)3.20
Book value per share (mrq)0.08

Cash flow statement

Operating cash flow (ttm)-10.88M
Levered free cash flow (ttm)-6.02M